Lincoln Pharmaceuticals Limited

LINCOLN

INE405C01035

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 10:49:17 24/05/2024 BST			5-day change	1st Jan Change
566 ^INR	-0.36%		-1.89%	-7.08%

05-16	Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
05-16	Lincoln Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022

July 20, 2022 at 01:00 pm

Lincoln Pharmaceuticals Limited announced resignation of Mr. Niren A. Desai from the post of Company Secretary & Compllance Officer of the Company with effect from closure of business hours on July 19, 2022.

Latest news about Lincoln Pharmaceuticals Limited

Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-16	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-16	CI
Lincoln Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31, 2024	05-16	CI
Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director	03-30	CI
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director	02-22	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-02	CI
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23	30/09/23	CI
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023	06/09/23	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23	CI
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023	25/05/23	CI
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company	25/05/23	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	25/05/23	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	09/02/23	CI
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director	05/12/22	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22	CI
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer	10/11/22	CI
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22	30/09/22	CI
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022	06/09/22	CI
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director	09/08/22	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	09/08/22	CI
Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022	20/07/22	CI
Lincoln Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31, 2022	19/05/22	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	10/02/22	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	11/11/21	CI

Chart Lincoln Pharmaceuticals Limited

Duration

Period

More charts

Company Profile

Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceuticals products like medicines, injections and other related products. The Companyâs product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid in bott, liquid injection and pharma products. It has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.

Sector

Pharmaceuticals

Calendar

05/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
LINCOLN PHARMACEUTICALS LIMITED	-7.08%	137M
ELI LILLY AND COMPANY	+38.69%	728B
NOVO NORDISK A/S	+33.85%	603B
JOHNSON & JOHNSON	-4.49%	360B
MERCK & CO., INC.	+20.24%	332B
ABBVIE INC.	+2.12%	279B
ASTRAZENECA PLC	+16.02%	244B
NOVARTIS AG	+7.72%	207B
ROCHE HOLDING AG	-5.56%	205B
PFIZER, INC.	-0.35%	163B